Marshall Wace
XRAY icon

Marshall Wace’s Dentsply Sirona XRAY Stock Holding History

Marshall Wace’s Portfolio XRAY Stock Details XRAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$40.3M Sell
3,800,116
-708,286
-16% -$7.73M 0.03% 450
2026
Q1 		$52.3M Buy
4,508,402
+2,271,616
+102% +$28.3M 0.05% 348
2025
Q4 		$25.6M Buy
2,236,786
+2,039,280
+1,033% +$23.9M 0.02% 551
2025
Q3 		$2.51M Buy
+197,506
New +$2.87M ﹤0.01% 1503
2025
Q2 		– Sell
-810,217
Closed -$12.1M – 3254
2025
Q1 		$12.1M Sell
810,217
-19,728
-2% -$350K 0.02% 700
2024
Q4 		$15.8M Buy
+829,945
New +$17.6M 0.02% 620
2024
Q2 		– Sell
-2,134,571
Closed -$70.8M – 3036
2024
Q1 		$70.8M Buy
2,134,571
+987,515
+86% +$33.7M 0.11% 179
2023
Q4 		$40.8M Buy
+1,147,056
New +$36.4M 0.07% 284
2022
Q1 		– Sell
-341,698
Closed -$19.1M – 4122
2021
Q4 		$19.1M Buy
341,698
+183,551
+116% +$10.1M 0.04% 507
2021
Q3 		$9.18M Sell
158,147
-280,282
-64% -$17.3M 0.04% 607
2021
Q2 		$27.7M Buy
438,429
+343,924
+364% +$22.7M 0.13% 170
2021
Q1 		$6.03M Buy
94,505
+47,260
+100% +$2.74M 0.03% 726
2020
Q4 		$2.47M Buy
+47,245
New +$2.33M 0.01% 861
2020
Q2 		– Sell
-134,522
Closed -$5.22M – 2006
2020
Q1 		$5.22M Buy
134,522
+134,422
+134,422% +$6.85M 0.05% 367
2019
Q4 		$6K Buy
+100
New +$5.58K ﹤0.01% 1613
2017
Q3 		– Sell
-13,847
Closed -$900K – 428
2017
Q2 		$900K Buy
+13,847
New +$875K 0.04% 202
2017
Q1 		– Sell
-1,700,940
Closed -$98.2M – 785
2016
Q4 		$98.2M Buy
1,700,940
+697,037
+69% +$41.2M 0.65% 27
2016
Q3 		$59.7M Buy
+1,003,903
New +$61.7M 0.42% 56
2014
Q4 		– Sell
-36,169
Closed -$1.65M – 1000
2014
Q3 		$1.65M Buy
+36,169
New +$1.7M 0.02% 477

Other funds holding XRAY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
SCA
Southpoint Capital Advisors New York $4.4B AUM 49.36% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

Marshall Wace's XRAY Position: Q2 2026 in Review

Marshall Wace reduced its Dentsply Sirona (XRAY) stake by 16% in Q2 2026, selling an estimated $7.73M and leaving 3,800,116 shares worth $40.3M. The position accounts for 0.03% of the portfolio, ranked #450.

Marshall Wace first reported a position in XRAY in Q3 2014 and has held it in 19 quarters since. The position peaked at $98.2M in Q4 2016. 373 funds tracked by Wall St. Rank hold XRAY as of Q2 2026.

  • Marshall Wace held 3,800,116 shares of Dentsply Sirona worth $40.3M as of Q2 2026.
  • Marshall Wace sold 708,286 Dentsply Sirona shares in Q2 2026, an estimated $7.73M.
  • Dentsply Sirona made up 0.03% of Marshall Wace's portfolio in Q2 2026, its #450 holding.
  • Marshall Wace first reported a position in Dentsply Sirona in Q3 2014 and has held it in 19 quarters since.
  • Marshall Wace's Dentsply Sirona position peaked at $98.2M in Q4 2016.
  • 373 funds tracked by Wall St. Rank held Dentsply Sirona as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.